Argenx
ARGX
#551
Rank
ยฃ27.02 B
Marketcap
ยฃ438.80
Share price
2.77%
Change (1 day)
44.81%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -ยฃ3.36

According to Argenx 's latest financial reports the company's current EPS (TTM) is -ยฃ3.24. In 2022 the company made an earnings per share (EPS) of -ยฃ10.21.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ3.36-67.05%
2022-ยฃ10.21